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The present paper is concerned with the working out of a  laboratory test, 
other than actual infection, which would indicate the efficacy  of vaccination 
with  the  inactivated  virus  of  Russian  spring-summer  encephalitis  through 
the determination of the titer of circulating antibody.  If a direct correlation 
exists between the antibody and immunity, the test should provide an indicator 
of the degree of immunity.  In  our laboratory such a  correlation has  been 
demonstrated  with  the  virus  of  equine  encephalomyelitis  (1-3),  but  the 
results were based on a  relatively short period,  after  immunization,  in the 
life-span of the animal.  Now, a  study is presented of the immune response 
of mice to vaccination with formalin-inactivated  virus that  includes  (a)  im- 
munity on intracerebral and on peripheral inoculation of test doses of active 
virus;  (b)  complement-fixing  substance, and  (c)  neutralizing  antibody deter- 
mined by intraperitoneal  and intracerebral  methods,  over a  period covering 
almost the entire life of the animal.  This paper will describe, furthermore, an 
enduring  immunity  of high  degree  that  develops following  a  single  course 
of  two  intraperitoneal  injections  of  formolized,  inactivated  virus.  Finally, 
the possible application of the results to vaccination of man will be discussed. 
The virus of Russian spring-summer encephalitis (4) is notably well adapted 
to investigations of the sort outlined, since it has a peripheral portal of entry, 
under natural conditions being transmitted to man by ticks, while furthermore 
it is pathogenic for mice (among other animals)  by several routes of inoculation, 
including  the subcutaneous and the intraperitoneal.  Subcutaneous injection 
as employed experimentally  approximates  the  natural  route  of infection  in 
man;  and  since  the pathogenicity of the virus when thus introduced  is not 
affected by the age of the mice employed, a challenge  subcutaneous injection 
is possible at any time during their life-span. 
* This study was carried out under the Commission on Neurotropic Virus Diae  _-~e~_, Board 
for the Investigation and Control of Influenza and Other Epidemic Diseases in the Army, Pre- 
ventive  Medicine Service, Office  of the Surgeon Genera], U. S. Army. 
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Kagan (S) reported that mice could be immunized by means of formolized virus of Russian 
spring-summer encephalitis.  Immunity to infection by intracerebral or subcutaneous routes 
was thereby achieved, but serum-neutralizing antibody, as determined by the intracerebral 
method, could not be detected until late; no correlation was made out between immunity and 
circulating antibody.  Smorodintsev (6), on the other hand, stated that there is a close correla- 
tion between immunity to infection by the subcutaneous route and circulating neutralizing 
antibody as determined by the intracerebral method, but his protocols were limited and his 
observations carried out for no longer than 2 months. 
It should be mentioned here that formolized virus of Russian spring-summer encephalitis 
has been used in epidemic areas as a vaccine in man apparently with good results (6). 
Materials and Methods 
Virus.--The strain of Russian spring-summer encephalitis virus used in this work was trans- 
ported in ticks (7) in 1941, from the laboratory of Dr. M. P. Chumakov in Moscow,  U.S.S.R., 
to that of Dr. R. R. Parker, Director of the Rocky Mountain Laboratory of the United States 
Public Health Service, at Hamilton, Montana.  This strain was made available to us by Dr. 
Parker and Dr. H. R. Cox in the fall of 1942,  through the Commission on Neurotropic Virus 
Diseases, in the form of mouse brain in 50 per cent glycerol.  From this material, successive 
mouse-to-mouse passages by the intracerebral route were carried out.  The virus has been 
kept in our laboratory with a minimum number of mouse passages (four or five), by storing a 
suspension of infected mouse brain in buffered distilled water in a carbon-dioxide refrigerator 
at --76° C.  As virus was needed, mice were inoculated intracerebrally with the stock suspen- 
sion and the required virus was obtained from their brains.  As diluent for the virus, except 
for the preparation of vaccine, fresh normal rabbit serum in physiological saline solution in a 
proportion of 1 to 9 was used. 
Animals.--AlbinomiceoftheW-Swissstrain(8)wereusedforthisstudy.  All animais were 
purchased from one dealer and their age and average weights determined; uniform ones were 
selected for each experiment.  Following injection with serial dilutions of virus, the mice were 
housed in metal boxes, each containing no more than four or five animals which had received 
the same dilution of virus.  This was done because mouse-to-mouse cage infection had been 
noted, probably the result of cannibalism, when large numbers of mice inoculated with different 
dilutions of virus were kept together.  By segregation according to dilutions used, transmis- 
sion of infection from one animal to another in the same cage was avoided, and it was assumed 
that when this did happen, the error could be limited within one dilution. 
Vacci, e.--Suspensions  of formaiin-inactivated virus were prepared as vaccines as follows: 
From the stock suspension of virus in the dry-ice refrigerator, a 10  -a suspension was made and 
groups of 40 to 50 mice, about 3 weeks old, were inoculated intracerebrally.  When sick or 
prostrate, usually on the 4th day after injection, they were sacrificed, their brains removed and 
emulsified in physiological saline solution in a Waring blendor to a concentration of 10 per cent 
mouse brain, and 0.5 per cent formalin was added (final concentration).  The suspension was 
stored in the refrigerator at 4 ° C. in a glass-stoppered flask and left there long enough for in- 
activation, usually 10 to 12 days.  At the end of that time, the vaccine was tested for virulence 
by intracerebral injection into ten mice, 20 to 22 days old.  They were observed for 21 days 
and if any of them died the test was repeated until no virus could be recovered from the vac- 
cine.  Since no preparation could be considered avirulent until the end of this test, vaccines 
were not used until 35 and 45 days after preparation, which was more than three times the 
number of days required to inactivate the virus under the conditions described.  No attempt 
was made to determine how long the vaccine might be stored and still be effective. 
VaccinaHon.--Mice were vaccinated by means of two intraperitoneal injections of 0.2 cc. 
each of the 10 per cent vaccine at 2 days' interval, making a total of 0.4 cc. of vaccine for each 
mouse.  Although solid immunity can be achieved with less vaccine, no attempt was made in 
these experiments to find out the smallest amount. J. CASALS AND P. K. OLITSKY  433 
Chagenge Teat.mAt definite intervals, before or after vaccination was begun, mice were 
tested for immunity to the virus.  Five mice, 22 to 25 days of age, received intracerebrally a 
10  ~  dilution of frozen virus.  When the animals were prostrate or sick, usually on the 4th day, 
their brains were removed, ground in a  mortar, and suspended in saline-serum (10 per cent 
rabbit serum in 0.9 per cent saline solution) diluent to a concentration of 10-L  This suspension 
was then centrifuged at 2000 g.v.zt, for  10 minutes,  the supemate removed and diluted with 
saline-serum in serial tenfold dilutions from 10  ~  to 10  "-u.  Vaccinated mice as wall as controls 
were inoculated with these suspensions, five animals usually  being employed for each dilu- 
tion; 0.5 co. of virus suspension was  introduced into the subcutaneous  tissue of the groin. 
When the intracerebral route was used, the inocuinm consisted of 0.03 co. 
lfeutralising Antibody.--For the investigation of circulating antibody, mice were bled from 
the heart under ether anesthesia,X the blood from individual animals was pooled and, after 
standing at room temperature for 1 hour,  centrifuged.  The sera were either tested immedi- 
ately after or were kept at --76  ° C. until studied.  Thus at the same definite intervals after 
vaccination when mice were tested for immunity, other mice from the vaccinated and control 
groups were bled and the material was kept frozen. 
Neutralizing antibody was detected by mixing undiluted serum with increasing dilutions of 
virus.  To this end, a 10-x fresh suspension of virus was prepared as described under Challenge 
test.  After centrifugation at 2000 R.v.zt. for 10 minutes, the supernate was further diluted in 
serial tenfold dilutions beginning with 2 X  10-  s and ending with 2 X  10  -1°.  0.4 cc. of each of 
these dilutions was added to 0.4 co. of undiluted serum deriving from control or from vaccinated 
mice.  The mixtures were incubated at 37  ° C. for 2 hours in a  water bath.  Two different 
routes of inoculation, intracerebrally with 0.03 cc. and intraperitoneally  with 0.1 cc., were used 
in mice 25 to 35 days old.  With each dilution five mice were injected for the intracerebral test 
and four for the intraperitoneal. 
Compl~nent-Fixing Antibody.--All samples of sera were tested for complement-fixing anti- 
body against the virus.  Mouse brain antigens were used; the method of procedure and of prep- 
aration of antigen has been described (9).  Antigen and serum controls were included, and in 
all eases the sera were tested against another unrelated brain antigen, e.g. of Western equine 
encephalomyelitis Or St. Louis encephalitis viruses, in order to rule out non-specific reactions. 
The highest dilutions of serum giving a 2+ or higher reaction determined the titer of the serum. 
Sera from both vaccinated and from control mice were always tested together. 
Estimation of End-Points, Neutralization and Immunity Index.--The mice used in this work 
were uniform in their response to inoculation of the virus regardless of their age.  Hence the 
detailed protocols of neutralization or immunity tests presented no difliculty for evaluation of 
the titer of the virus.  The L.D.s0 titer was calculated according to the formula of Reed and 
Muench (10).  From this the immunity or neutralization index was obtained as the ratio be- 
tween L.D.~0 of virus in vaccinated mice and in control mice (the index of the latter being 
taken as 1).  For simplification, neutralization or immunity indices of 1 to 50 were expressed 
as the nearest whole number, of 50 to 100 to the nearest 10, 101 to 1000 to the nearest 100,  1001 
to 10,000 to the nearest 1000, and so on. 
EXPERE~ENTAL 
Correlation of Serum-Antibody witk Immunity on 
Peripheral Inoculation of Virus 
The  type  and  degree  of  correlation  between  circulating  antibody  and  im- 
mtmity  on peripheral inoculation of a  test dose of virus in a  vaccinated mouse 
were determined  from the results of the two following experiments. 
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TABLE I 
Immunity on Challenge Tests,  Virus-Neutralizing,  and Complement-Fixlng Antibodies in 
iMic,, Following Vaccinaiion with Formalin-Inaaivated  Virus o/Russian Spring-Summer 
Encephalitis 
Dosfy 
Treat- 
ment 
test  of mice 
Immunity of mice  .on 
subcutaneous injection 
of virus 
Neutralization test with sets of mice 
Intracerebral route  IntraperitoneaI mute 
Neutral 
w.v~e  Immunity index  I.~e  izstion  L.Dae 
index 
--4  V  8.7  -1 
C  8.6 
-2  V  7.5  -2 
C  7.3 
2  V  <2.0  >4,000,000  7.8  4  7.2 
C  8.6  8.4  8.0 
3  V  <3.5  >30,000  7.4  2 
C  8.0  '  7.7 
6  V  <1.5  >12,000,000  7.6  4  6.8 
C  8.6  8.2  8.2 
7'  V  <2.5  >300,000  7.2  1 
C  8.0  7.3 
13  V  <1.5  >63,000,000  6.6  8  <1.5 
C  9.3  7.5  7.8 
14  V  <1.5  >16,000,000  6.7  6 
C  8.7  7.5 
21  V  <1.5  >50,000,000  6.8  5  <2.0 
C  9.2  7.5  7.2 
29  V  <1.5  >50,000,000  7.0  6  <2.0 
C  9.2  7.8  7.7 
31  V  <1.5  >200,000  7.3  1  2.0 
C  6.8  7.4  8.3 
61  V  <1.5  > 10,000,000  7.4  2  3.9 
C  8.5  7.6  7.4 
120  V  <1.5  >3,000,000  7.0  6  2.0 
C  8.0  7.8  8.2 
Comple- 
ment-~xing 
titer of sera 
~eutrallzsfion 
index 
6  0 
0' 
0 
0 
25  1:2 
0 
1:8 
0 
>2,000,000  1:16 
0 
1:16 
0 
>160,000  1:16 
0 
>500,000  1:16 
0 
2,000,000  1:16 
0 
3,000  1:2 
0 
1,600,000  1:8 
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TABLE I--Concluded 
T 
test 
224 
348 
437 
Treat- 
ment 
of mlee 
V 
C 
V 
C 
V 
C 
t~mlty  of mice on 
subcutaneous injection 
L.DJO 
<1.5 
8.7 
<2.5 
8.0 
<1.5 
8.4 
of virus 
Immunity index  x,.vam 
> 16,000,000  7.5 
8.4 
>300,00O  6.7 
7.5 
>8,000,000  5.6 
6.5 
Neutralization teat with sere of mice 
!  Intracerebral route 
Neutral- 
i~tion 
index 
Iatrtl~itoneal route 
r..D~  m Neutralization 
index 
3.3  10,000 
7.3 
2.4  20,000 
6.7 
<2.0  >30,000 
6.5 
Cemple- 
ment-fixlng 
tites of se~m 
1:2 
0 
1:2 
0 
1:2 
-0 
X..D,so == log of dilution giving the 50 per cent end-point. 
Immunity index ffi ratio between L.D.so of virus in vae£inated mice and in control mice. 
Neutralization index ffi ratio between x-v.me of virus in presence of serum from vaccinated 
mice and that in presence of serum from control mice. 
Complement-fixing titer ffi highest dilution of serum giving a 2+ or better reaction.  First 
dilution is 1:2. 
V  ffi vaccinated, C  ffi control, not vaccinated.  Neutralization and immunity index of 
control is 1. 
Experiment 1.--700 mice, 60 to 90 days of age and weighing from 20 to 26 gm. at the-begin- 
ning of the experiment, were selected.  350 were set aside as untreated controls; the other 350 
were vaccinated with formalin-inactivated, mouse brain vaccine which had been prepared 45 
days before its use.  Two injections of 0.2 cc. each were given intraperitoneally at 2 days' in- 
terval.  Then at intervals of 3, 7, 14, 21, 29, 61, 120, 224, and 348 days, testsfor immunity on 
subcutaneous injection of virus and for neutralizing and complement-fi~ng antibody were per- 
formed in the groups of vaccinated mice and corresponding controls. 
Experiment 2.--This experiment was a repetition of the first; here the tests for immunity 
and for the presence of antibody were carried out at other intervals.  In addition, two groups 
of mice were injected with virus first and then vaccinated, in order to ascertain whether vac- 
cination following exposure would be effective. 
680 mice from 40 to 70 days old at the beginning of the test were selected and of these 300 
were kept untreated as controls.  The others were immunized in the same way as in Experi- 
ment 1, that is, 0.2 cc. of vaccine was given twice, the vaccine having been prepared 35 days 
before.  Two groups of the latter mice were  injected  subcutaneously with virus 4  and 2 
days before they were given the first dose of vaccine.  The corresponding controls were in- 
jected with virus alone; i.e., no vaccine was given them.  The remaining animals, vaccinated 
in the usual way, and untreated, control mice, were tested in groups for peripheral resistance 
and antibodies at the following intervals from the date of the first dose of vaccine: 2, 6, 13  31, 
and 437 days.  Besides, tests for circulating antibody, although not for immunity, were car- 
ried out 203 and 206 days after vaccination.  Finally, on the 437th day, a group of mice were 
tested for immunity on intracerebral, as well as on subcutaneous inoculation of virus. 
Immunity  to  Virus  Given  Subcutaneously.--Since  the  results  obtained  in 
both  experiments were  similar,  they were  combined and  are shown  in  Tables 436  RUSSIAN SPRING-S~R  ENCEPHALITIS 
I  and II and graphically in Text-fig. 1.  It is apparent that a  single  course 
of two doses of vaccine induced a  solid protection against virus  given sub- 
cutaneously at  varying intervals  from  2  days  to  15  months.  It  was  not 
possible in any of the tests to bring down a vaccinated mouse (with the only 
exception of two on the 2nd day test), even when a 10  -2 dilution of virus (i.e., 
from 100 thousand to 10 million lethal doses) was given.  Therefore the values 
of the immunity index as stated are only an indication of the minimal amount 
of virus resisted, since no end-point reading was obtained in the  vaccinated 
mice.  The fluctuations in the values of the immunity index are due  to the 
fact that the titer of the virus in the controls varied from test to test from a 
minimum of 10  -6'8 to 10  -9'3.  Vaccination carried out 4 and 2 days after injec- 
tion of virus did not modify the degree of the induced immunity. 
Immunity to Virus Given Intracerebrally.--On the 437th day after vaccina- 
tion, mice were challenged by active virus introduced into the brain (Table HI). 
Vaccin~ed mice revealed s~.arcely any immunity to the test dose of virus as 
compared, with controls: the L.D.50 was 10-  7.3 in the vaccinated, and 10  -~-~ in 
the unvaccinated.  On the other hand, mice similarly vaccinated but tested 
subcutaneously had, on the same (the 437th) day, a solid immunity (Table II) 
to8 million, at least, ~..L.D.: Other instances were observed which added to 
the evidence that it is difficult to induce immunity to virus given intracere- 
brally, by means of similar dosages of formalin-inactivated virus of Russian 
spt.ing-summer encephalitis.  Thus a  wide difference exists in the degree of 
protectid  n afforded by a  given preparation of inactivated virus, according to 
the route (intracerebral or peripheral)  used for the challenge test. 
Serum-Neutralizing Antibody.--A  striking contrast was found in the results 
of  neutralization  tests  performed  by  intraperitoneal  and  by  intracerebral 
routes.  As  shown in Tables I  and II and  Text-fig. 1, mixtures of virus and 
antiserum introduced intracerebrally gave neutralization indices in vaccinated 
series  between  1  (i.e., the  same  as  for the  controls)  and  8.  According to 
accepted practice these low values might be taken to indicate that no circulating 
antibody was present in the vaccinated mice.  The same serum-virus mixtures, 
however, when injected intraperitoneally, yielded an entirely different result: 
Neutralizing indices of the sera from vaccinated mice were 6 on the 2nd day, 
25 on the 6th, 2,000,000 or more on the 13th and 31st days, and high thereafter 
to the 437th day after vaccination.  Again here, as with the index of immunity 
to infection, an end-point of the higher values was not often reached.  The 
neutralization index (Table  I)  represents only the minimal number of ~.L.1). 
against  which  sera  protected.  To  conclude,  a  correlation  was  observed 
between  immunity  on  peripheral  injection  of  virus  and  circulating  neu- 
tralizing  antibody  as  determined  by  the  intraperitoneal  route.  Only  on 
the earliest days, namely, the 2nd and 6th, was solid immunity after injection 
of virus unaccompanied by as high a  titer of neutralizing antibody as in the 
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Complement-Fixing Antibody.--Complement-firfing  antibody  revealed  itself 
on the 6th day following vaccination with a  1:2  titer which became 1:16 in 
about 2 weeks and remained there or somewhat lower, 1:8, to the 4th month. 
TABLE II 
Results of Immunity and Neulragdzation Tests in Mice Vaccinated  wi.~Is  Formalin-Inactimted 
Virus of Russian Spring-Summer Emepkalitis 
Day 
of 
test 
--4 
--2 
2 
6 
13 
21 
29 
61 
120 
224 
348 
437 
Treat- 
ment of 
mice 
-2 
V 
C 
V 
C 
V 
C 
V 
C 
V 
C 
V 
C 
V 
C 
V 
C 
V 
C 
V 
C 
V 
C 
Tmmnn_ity  test 
Fate of mice given virus in 
dilution  (log) 
I 
ol 
OI 
0 
0 
0 
0 
0 
-3--4-5 
5  5  5 
5  5  4 
I  0  0 
0  0  0 
0  0  0 
0  0  0 
5  5 
0  0  0 
5  5 
0  0  0 
5 
0  0  0 
0  0  0 
t/4 
~131  oI~ )13 
t/4 
0  0  0 
U4 V4 
--6 -71-8  -9  -I0 
5  514  2* 
515  1  0 
4  412  2 
5  3Jl  0  0 
00lO  0 
5  515  1  0 
i 
0  OlO 
55[42-  0 
0~010 
5  515  3  1 
0  0100 
5  515  3  0 
0  OlO 
5  515  3  0 
0  OlO 
5  514  1  1  I 
0  010 
5  413  D  0 
0  0 
t/44/4[4/4  l/4  )/4~[ 
)13 OlJ 
V4 3/412/4 )/4 V4 
0  0 
,/4,  U414/4 [/4 V4 
i 
0 
0) 
Intracerebral neutraliza- 
tion test 
Fate of  mice given virus 
in  dilution  (log) 
Intraperitoneal  neutraliza- 
tion  test 
Fate of mice gwen virus 
in dilution  log) 
--4  -0  -8 
3  3  1 
4  4 
4  3  2  2 
4  4  2 
0  0  0 
3  2 
0  0  0  0 
4  4  2  1 
1  0  0  0 
4  4  1 
0  2  0 
3i4  4  0 
liO  0  0 
42~4  3  3 
1  I  0  0 
4  4  3  0 
0  I  1  0  , 
4  4  I  0 
I  0  0  ~  0 
4  4 
21-_7 ¸~  ....  *-"  -°i 
,552  0  3 
5  4  3J0 
5 5 t  ~l o  3 I 
553  0 
510  0  0  541ilo 
421310  1  0 
54  I  0  4 
5  2  1  0  I 
552  0  4 
540)  0  3 
551  )  0 
5  5  2  I  )  1  1 
552)  0 
5541  31 
544  0 
55110  0  1 
550  0 
i 
o 
5 [0  0  0 
-10 
0  0 
0  0 
0  0 
0 
*  Mice dead of  5 inoculated (in  intraperitoneal  test,  of  4 inoculated). 
~: 4/4 ~  4 mice dead of virus infection of 4 used in test. 
Thereafter the titer was low, 1: 2, or negative.  In view of this low reading: at 
stated intervals after the  4th  month, one might assume that the complement- 
fixation test is of dubious value as an indicator of immunity.  However, when 
the test was positive, the immunity on peripheral inoculation of virus was of 
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TEXT-FIG.  1.  Immunization by intraperitoneal injection of formalin-inactivated virus of 
Russian spring-summer encephalitis. 
TABLE III 
Immunity on Intracerebral Injection of Russian Spring-Summer  Encephalitis Virus in Mice 
Vaccinated with  Formalin-Inactivated Vaccine 
437th Day from Vaccination 
Treatment of  Fate of mice given vtrus m diction (log)  Immtmi~ 
mice  L.D.so  index 
-4  -$  -6  -7  I  -8  -9  -10 
V  4/4  4/4  4/4  3/4  0/4  0/4  7.3  2? 
C  3/3  3/3  2/4  1/4  1/4  0/4  7.5 
See other tables for abbreviations. 
Neutralizing Antibody Following Virus Inoculation 
during a Late Stage of Active Immunity 
The correlation of immunity, on subcutaneous infection, with high  titer of 
antibody,  as  determined  by  the  intraperitoneal method,  together  with  the 
absence  of  appreciable  immunity  on  intracerebral  introduction  of  virus, 
suggested that  the  circulating  antibody prevented the  spread  of virus from 
theTsite of inoculation to the central nervous system, as happens in the case of ~. CASALS  AND P. K. OL1TSKY  439 
equine encephalomyelitis virus  (1, 11).  Additional evidence for this was found 
by following the titers of neutralizing antibody in mice vaccinated as described 
and then, at a much later date, exposed to the virus by the subcutaneous route. 
Expedm¢~ 3.--One group of vaccinated  mice from Experiment I and another of corre- 
sponding controls were bled on the 120th day after vaccination.  Ten additional  vaccinated 
mice were injected subcutaneously with 0.S cc. of virus in a 10-6dilution (approximately  1000 
lethal doses).  3, 10, and 21days after inoculation of virus, these mice were b]ed from the heart 
7.0 
6.0 
I~.0 
4- 
~.  IpU 
LO[ I~  t  ~  J  ,  I 
0  ,~  10  21  ~)Czy~  Qfte~  fn~ecttO~. 
of te=~ c~o=e of ¢6~ve v.~u= 
TF.~xT-FIG. 2. Neutralization tests by intracerebral  and intraperitoneal  methods following 
vaccination and injection of test doses of active virus given on the 120th day after vaccination. 
and the sera tested for neutralizing antibody both by intracerebra] and intraperitoneal  routes. 
Between the interval of b]eeding and the test, the sera were kept frozen.  Although the blood 
had been derived from mice inoculated with active virus, it was not infective.  The sera were 
tested simultaneously with those derived from mice not given test doses of virus, on the 120th 
day after vaccination.  The results, shown graphically in Text-fig. 2, revealed a definite drop 
in the amount of virus neutralized  by serum by the intraperitoneal  test, especially on the 3rd 
day after injection of virus.  The neutralization  index of the serum increased on the 10th day 
and was at the same leve], or even higher than it was originally, on the 21st day.  The results 
of neu~tion  by the intracerebral  test paralleled  those obtained by the intraperitoneal 
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•  It would seem from this test that the introduction of active virus into animals 
already having neutralizing antibody brings about within a few days a drop in 
the protective power of their serum, as though the antibody were beingused 
for the neutralization of the virus introduced into the immune animals (cJ. 
S chlesinger: olitsky  ,  and Morgan  ,  12).  Eventually, within about 3  weeks, 
the serum either regains the original high titer or shows a still higher fiter than 
ever before. 
DISCUSSION 
The immunity of albino mice after a  single course of two injections of 0.2 
cc.  of formalin-inactivated vh'us of Russian spring-summer encephalitis has 
been  observed, with tests for immunity given just  before vaccination,  and 
at varying periods from 2 days to  15 months after vaccination.  At  the final 
period, the oldest  mice were about  1½ years  of  age, and all  of  them  were 
showing signs of old age.  The vaccines employed were free from active virus 
in so far as the present tests  could show:  (1)  Vaccines were  injected 35  and 
45 days after preparation and in no instance has active virus been recovered 
after 12 days' formalinization.  (2)  Virus was not recovered from the blood 
deriving from vaccinated animals and collected 1 hour, or later, after treatment. 
(3)  Mice exhibited no visible signs of illness after vaccines were introduced 
intracerebrally or intraperitoneally. 
After vaccination, an immunity of such pronounced character prevails in 
mice during almost a  lifelong period  that they can resist many thousands of 
lethal doses of virus injected peripherally.  This finding is in  line with the 
encouraging results of vaccination of man against the Russian spring-summer 
virus observed by Smorodintsev and his coUeagues (6).  The fact that a strong 
and  enduring  immunity results  from subcutaneous  injection  of  inactivated 
virus is a  point of practical interest.  Such an immunity, following a  single 
course of injections, is highly unusual, and is ordinarily called forth only by 
infection with virus, or through the persistence of the latter within the body 
of the host (so called "persistence immunity"). 
It  should  be  pointed  out,  however,  that  the  total  amount  of  formalin, 
inactivated virus given in the single course of vaccination (0.4 cc.) is an extra- 
ordinarily large  amount.  The  dosage was  selected at random, no  attempt 
having been made to find the minimal amount of vaccine which would be 
needed to induce so great an immunity.  The amount required in mice may 
give no index to the quantity needed for effective immunization of other species 
including man, as was shown by Cox and Olitsky (13) in connection with the 
relative dosages of equine virus vaccines needed for the protection of the mouse 
and the horse, as well as by Beard et al. (14) for the production of neutralizing 
antibody against the latter virus in the mouse and in man. 
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to the virus and that on intracerebral.  For example, mice tested about  15 
months after vaccination exhibited resistance to at least 8 million lethal doses 
of virus introduced subcutaneously but not to more than two doses of virus 
injected into the brain.  It is probable that the immune reaction is consum- 
mated chiefly in the tissues and blood at some place between the site of intro- 
duction of the virus and its entrance into the central nervous system.  How- 
ever this may be,  the  intracerebral  method of testing for immunity is not 
sufficiently delicate  to  indicate  the  degree  of  immunity developed.  The 
challenge  test  for  efficacy of preparations  of  vaccines  should  therefore  be 
carried out by peripheral routes which offer a more delicate test, as shown by 
Cox and Olitsky (13) for equine encephalomyelitis virus, and by Webster (15) 
for rabies virus.  The  results, furthermore, can be  better correlated with a 
natural disease in which the portal of entry of the virus is peripheral, as by 
an insect or tick bite. 
A noteworthy disparity in result is encountered when the neutralization test 
is performed by the intracerebral and by the intraperitoneal routes respectively, 
intraperitoneal injection being far the more  efficacious.  The difference has 
already been pointed out for several viruses (1'6, 17).  In mice vaccinated with 
the Russian spring-summer encephalitis virus the neutralization index by the 
intracerebral method was 8 or less; by the intraperitoneal, later than the 6th 
day after vaccination to the  15th month, several thousand to more than 2 
million.  Indeed, in one instance the intracerebral test showed a neutralization 
index of 1--the value for the control--while th~ intraperitoneal exhibited an 
index of 2 million.  However, with one or two exceptions in a  score of tests, 
the readings of the intracerebral neutralization test were higher than 1, that is, 
2 to 8, numbers generally considered hitherto as not significant in indicating 
neutralization of neurotropic viruses (18).  But such low indices have meaning 
since  (a)  they can be obtained on repetition;  (b)  they are  correlated with a 
large  amount  of  antibody--never  with  an  absence---as  determined  by  the 
intraperitoneal test and  (c) neutralizing antibody revealed by the latter test 
exhibits a  close  correlation with immunity to peripheral  challenge doses  of 
Russian spring-summer virus. 
With respect  to  correlation of immunity to  circulating antibody, it is  of 
interest that the index of immunity on intracerebral injection of virus on the 
437th  day after vaccination was  2,  whereas  on the  subcutaneous challenge 
dose it was greater than 8 million.  The intracerebral immunity index at 2 
was of the same magnitude as the intracerebral neutralization index; the high 
index of immunity on subcutaneous test with active virus was in effect associ- 
ated with the high index of neutralization shown by the intraperitoneal method. 
This seems to be the interrelation, in general, of the four factors involved, and 
may apply to other neurotropic viruses as well (16,  17).  The practical point 
is that tests for potency of vaccines should, when possible, depend on the use 442  RUSSIAN SPRING-SUSIe.2 ENCEPHALITIS 
of peripheral  routes both  for  the  challenge  test  for  immunity  and  for  the 
neutralization test for antibody.  It should be stated here that the low indices 
of neutralization  obtained by the intraperitoneal  route on the  2nd and  6th 
days after vaccination do not disturb the concept of a correlation of immunity 
with neutralizing  antibody; for the incubation period of the Russmn spring- 
summer virus is 8  to  12  days following  its subcutaneous introduction.  In 
the earliest phase following vaccination the production of antibody proceeds 
apace and it is apparent that a sufficient amount is available to block the pro- 
gression  of virus from the site of injection to the central nervous system. 
Attention should be drawn to the fact that  the possible presence of virus 
in the test serum in early days after the challenge exposure of vaccinated mice 
to active virus may serve to reduce the amount of detectable antibody (Text: 
fig. 2)  (12). 
Finally,  the  relation  of complement-fixing  antibody to  immunity in  vac- 
cinated mice is not as dose as that  of neutralizing  antibody: the former is 
slower in development and  persists for a  shorter time--after  4  months  the 
titer is low or practically negative.  Its presence is,  however, accompanied 
by solid immunity whereas the "converse does not hold. 
The findings here reported on the production in mice of an enduring, staunch 
immunity developed through  the use of formalin-inactivated  virus;  the cor- 
relation of immunity with serum-neutralizing  antibody, and the demonstration 
of effective immunization  by titration  of such antibody by means of appro- 
pilate  tests, may have application  to vaccination  of man  with  the Russian 
spring-summer  encephalitis  virus.  How  far  these  applications  go  can  be 
determined only by trials in the field. 
CONCLUSIONS 
A  single  course  of  two  intraperitoneal  injections  of  formalin-inactivated 
virus of Russian spring-summer encephalitis induced in albino mice a  solidly 
immune state which endured almost throughout life.  Active virus is therefore 
not essential for the production of a  high degree of lasting immunity.  The 
immune  response  to vaccination consists of resistance  to peripherally  intro- 
duced active virus and development of circulating  antibody. 
A  correlation  has been found  to exist throughout  the  long  period  of the 
immune state between the titer of neutralizing antibody, as determined by the 
intraperitoneal method described, and the degree of immunity to peripherally 
introduced active virus.  Thus laboratory tests for the immunizing  power of a 
vaccine suggest themselves, to be carried out by an estimation in vaccinated 
mice of (a)  immunity to peripherally inoculated activo virus, and  (b) serum 
virus-neutralizing  antibody determined by the intraperitoneal  method. 
The  r61es as indicators  of immunity  in  vaccinated  mice  of  complement- 
fixing antibody in the serum, of the intracerebral challenge  dose of virus, and 
of the intracerebral  method for testing  neutralizing  antibody are discussed. J'. CASALS  AND P. K. 0Lr£SKY  443 
Finally, if the immune response of man to vaccination with formalin-inacti- 
vated virus of Russian spring-summer encephalitis follows the pattern of the 
response of mice as here described, and if the correlation of neutralizing anti- 
body with immunity to peripherally introduced virus applies  to man as to 
mice, then possibly the degree of immunity in human beings following vac- 
cination can be appraised by a peripheral test for neutralizing antibody in the 
serum. 
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